Search results
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 9 hours agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 10 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 12 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
The Wall Street Journal· 4 days agoNovavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to...
Novavax Shares Pop Another 50% Following Sanofi Deal
Market Watch· 9 hours agoShares of Novavax continued their ascent on Monday, adding to gains from last week after the company announced a licensing deal with Sanofi. Novavax said ...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 4 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Why Is Novavax (NVAX) Stock Up 118% Today?
InvestorPlace· 4 days agoNovavax (NASDAQ:NVAX) stock is on the rise Friday after the biotechnology company announced a deal with Sanofi (NASDAQ:SNY) alongside its first-quarter ...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Company News For May 13, 2024
Zacks via Yahoo Finance· 14 hours agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine....
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...